Reconstructing eukaryotic NAD metabolism

BioEssays

Volumn 25, Issue 7, 2003, Pages 683-690

  Rongvaux, Anthony ^a   Andris, Fabienne ^a   Van Gool, Frédéric ^a   Leo, Oberdan ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINIC ACID; TRYPTOPHAN; VITAMIN;

CHEMICAL ANALYSIS; COENZYME; ENZYME ACTIVITY; EUKARYOTE; HUMAN; METABOLIC REGULATION; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION REACTION; PELLAGRA; PRECURSOR; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; REVIEW;

ADENOSINE DIPHOSPHATE RIBOSE; ANIMALS; EUKARYOTIC CELLS; HUMANS; NAD; TRYPTOPHAN;

EUKARYOTA;

EID: 0037829279     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.10297     Document Type: Review

References (66)

1. Ziegler M. New functions of a long-known molecule. Emerging roles of NAD in cellular signaling. Eur J Biochem 2000;267:1550-1564.
2. Koch-Nolte F, Reche P, Haag F, Bazan F. ADP-ribosyltransferases: plastic tools for inactivating protein and small molecular weight targets. J Biotechnol 2001;92:81-87.
3. 2+-mobilizing activity. J Biol Chem 1989;264:1608-1615.
4. Guse AH. Cyclic ADP-ribose. J Mol Med 2000;78:26-35
5. Frye RA. Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem Biophys Res Commun 1999;260:273-279
6. Imai S, Armstrong CM, Kaeberlein M, Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 2000;403:795-800.
7. Moazed D. Enzymatic activities of Sir2 and chromatin silencing. Curr Opin Cell Biol 2001;13:232-238.
8. +-dependent deacetylases. J Biol Chem 2002;277:12632-12641.
9. Lin SJ, Defossez PA, Guarente L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 2000;289:2126-2128.
10. Tissenbaum HA, Guarente L Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 2001;410:227-230.
11. Guarente L. Sir2 links chromatin silencing, metabolism, and aging. Genes Dev 2000;14:1021-1026.
12. D'Amours D, Desnoyers S, D'Silva I, Poirier GG. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J 1999;342: 249-268.
13. Krehl WA, Trepley LJ, Sarma PS, Elvejhem CA. Growth retarding effect of corn in niacin-low rations and its counteraction by tryptophan. Science 1945;101:489-490.
14. Bender DA, Olufunwa R Utilization of tryptophan, nicotinamide and nicotinic acid as precursors for nicotinamide nucleotide synthesis in isolated rat liver cells. Br J Nutr 1988;59:279-287.
15. Wolf H. Studies on tryptophan metabolism in man. Scand J Clin Lab Invest Suppl 1974;136:1-186
16. Schutz G, Feigelson P. Purification and properties of rat liver tryptophan oxygenase. J Biol Chem 1972;247:5327-5332.
17. Knox WE, Mehler AH. The adaptive increase of the tryptophan peroxidase oxidase system of liver. Science 1951;113:237-238.
18. + synthesis. Adv Enzymol Relat Areas Mol Biol 1999;73:135-182.
19. Nishizuka Y, Hayaishi O. Studies on the biosynthesis of nicotinamide adenine dinucleotide. I. Enzymatic synthesis of niacin ribonucleotides from 3-hydroxyanhranilic acid in mammalian tissues. J Biol Chem 1963; 238:3369-3377.
20. Shimizu T, Nomiyama S, Hirata F, Hayaishi O. Indoleamine 2,3-dioxygenase. Purification and some properties. J Biol Chem 1978;253: 4700-4706.
21. Yamazaki F, Kuroiwa T, Takikawa O, Kido R. Human indolylamine 2,3-dioxygenase. Its tissue distribution, and characterization of the placental enzyme. Biochem J 1985;230:635-638.
22. Yoshida R, Imanishi J, Oku T, Kishida T, Hayaishi O. Induction of pulmonary indoleamine 2,3-dioxygenase by interferon. Proc Natl Acad Sci USA 1981;78:129-132.
23. Yoshida R, Hayaishi O. Induction of pulmonary indoleamine 2,3-dioxygenase by intraperitoneal injection of bacterial lipopolysaccharide. Proc Natl Acad Sci USA 1978;75:3998-4000.
24. Yoshida R, Urade Y, Tokuda M, Hayaishi O. Induction of indoleamine 2,3-dioxygenase in mouse lung during virus infection. Proc Natl Acad Sci USA 1979;76:4084-4086.
25. Takikawa O, Yoshida R, Kido R, Hayaishi O. Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase. J Biol Chem 1986;261: 3648-3653.
26. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown C, Mellor AL. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998;281:1191-1193.
27. Mellor AL, Sivakumar J, Chandler P, Smith K, Molina H, Mao D, Munn DH. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2001;2:64-68.
28. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 1999;189:1363-1372.
29. Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, Ferrara GB. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 2002;196:459-468.
30. Terness P, Bauer TM, Rose L, Dufter C, Watzlik A, Simon H, Opelz G. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites J Exp Med 2002;196:447-457.
31. Fallarino F, Grohmann U, Vacca C, Bianchi R, Orabona C, Spreca A, Fioretti MC, Puccetti P. T cell apoptosis by tryptophan catabolism. Cell Death Differ 2002;9:1069-1077.
32. Pfefferkorn ER. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci USA 1984;81:908-912.
33. Byrne GI, Lehmann LK, Landry GJ. Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect Immun 1986;53:347-351.
34. Heyes MP, et al. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 1992; 115:1249-1273.
35. Espey MG, Moffett JR, Namboodiri MA. Temporal and spatial changes of quinolinic acid immunoreactivity in the immune system of lipopolysaccharide-stimulated mice. J Leukoc Biol 1995;57:199-206.
36. Shibata K, Hayakawa T, Iwai K. Tissue distribution of enzymes concerned with the biosynthesis of NAD in rats. Agric Biol Chem 1986;50: 3037-3041.
37. Elvejhem CA, Madden RJ, Strong FM, Wolley DW. Relation of nicotinic acid and nicotinic acid amide to canine black tongue. J Am Chem Soc 1937;59:1767-1768.
38. Preiss J, Handler P. Biosynthesis of diphosphopyridine nucleotide. I. Identification of intermediates. J Biol Chem 1958;233:488-492.
39. Jacobson EL, Dame AJ, Pyrek JS, Jacobson MK. Evaluating the role of niacin in human carcinogenesis. Biochimie 1995;77:394-398.
40. Schweiger M, Hennig K, Lerner F, Niere M, Hirsch-Kauffmann M, Specht T, Weise C, Oei SL, Ziegler M. Characterization of recombinant human nicotinamide mononucleotide adenylyl transferase (NMNAT), a nuclear enzyme essential for NAD synthesis. FEBS Lett 2001;492:95-100.
41. Emanuelli M, Carnevali F, Saccucci F, Pierella F, Amici A, Raffaelli N, Magni G. Molecular cloning, chromosomal localization, tissue mRNA levels, bacterial expression, and enzymatic properties of human NMN adenylyltransferase. J Biol Chem 2001;276:406-412.
42. Raffaelli N, Sorci L, Amici A, Emanuelli M, Mazzola F, Magni G. Identification of a novel human nicotinamide mononucleotide adenylyl-transferase. Biochem Biophys Res Commun 2002;297:835-840
43. Zhang X, Kurnasov OV, Karthikeyan S, Grishin NV, Osterman AL, Zhang H. Structural characterization of a human cytosolic NMN/NaMN adenylyltransferase and implication in human NAD biosynthesis. J Biol Chem 2003;278:13503-13511.
44. Joshi JG, Handler P, Purification and properties of nicotinamidase from Torula cremoris. J Biol Chem 1962;237:929-935.
45. Frothingham R, Meeker-O'Connell WA, Talbot EA, George JW, Kreuzer KN. Identification, cloning, and expression of the Escherichia coli pyrazinamidase and nicotinamidase gene, pncA. Antimicrob Agents Chemother 1996;40:1426-1431.
46. Ghislain M, Talla E, Francois JM. Identification and functional analysis of the Saccharomyces cerevisiae nicotinamidase gene, PNC1. Yeast 2002;19:215-224.
47. Petrack B, Greengard P, Craston A, Sheppy F. Nicotinamide deamidase from mammalian liver. J Biol Chem 1965;240:1725-1730.
48. Su S, Albizati L, Chaykin S. Nicotinamide deamidase from rabbit liver. II. Purification and properties. J Biol Chem 1969;244:2956-2965.
49. Lin LF, Lan SJ, Richardson AH, Henderson LM. Pyridine nucleotide synthesis. Purification of nicotinamide mononucleotide pyrophosphorylase from rat erythrocytes. J Biol Chem 1972;247:8016-8022.
50. Carson DA, Seto S, Wasson DB. Pyridine nucleotide cycling and poly(ADP-ribose) synthesis in resting human lymphocytes. J Immunol 1987;138:1904-1907
51. Preiss J, Handler P. Enzymatic synthesis of nicotinamide mononucleotide. J Biol Chem 1957;225:759-770.
52. Dietrich LS, Fuller L, Yero IL, Martinez L. Nicotinamide mononucleotide pyrophosphorylase activity in animal tissues. J Biol Chem 1966;241: 188-191
53. Streffer C, Benes J. Nicotinamide mononucleotide. Determination of its enzymatic formation in vitro and its physiological role for the biosynthesis of nicotinamide-adenine dinucleotide in mice. Eur J Biochem 1971;21: 357-362.
54. Elliott GC, Rechsteiner MC. Evidence for a physiologically active nicotinamide phosphoribosyltransferase in cultured human fibroblasts. Biochem Biophys Res Commun 1982;104:996-1002.
55. Martin PR, Shea RJ, Mulks MH. Identification of a plasmid-encoded gene from Haemophilus ducreyi which confers NAD independence. J Bacteriol 2001;183:1168-1174.
56. Rongvaux A, Shea RJ, Mulks MH, Gigot D, Urbain J, Leo O, Andris F. Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol 2002;32: 3225-3234
57. Espey MG, Namboodiri MA. Selective metabolism of kynurenine in the spleen in the absence of indoleamine 2,3-dioxygenase induction. Immunol Lett 2000;71:67-72.
58. Zerez CR, Roth EF, Jr, Schulman S, Tanaka KR. Increased nicotinamide adenine dinucleotide content and synthesis in Plasmodium falciparum-infected human erythrocytes. Blood 1990;75:1705-1710.
59. Panozzo C, Nawara M, Suski C, Kucharczyka R, Skoneczny M, Becam AM, Rytka J, Herbert CJ. Aerobic and anaerobic NAD+ metabolism in Saccharomyces cerevisiae. FEBS Lett 2002;517:97-102.
60. Baglioni C. Genetic control of tryptophan pyrrolase in Drosophila melanogaster and Drosophila virilis. Heredity 1960;15:87-96.
61. Ghosh D, Forrest HS. Enzymatic studies on the hydroxylation of kynurenine in Drosophila melanogaster. Genetics 1967;55:423-431.
62. Gerdes SY, et al. From genetic footprinting to antimicrobial drug targets: examples in cofactor biosynthetic pathways. J Bacteriol 2002;184:4555-4572.
63. Jacobson EL, Shieh WM, Huang AC. Mapping the role of NAD metabolism in prevention and treatment of carcinogenesis. Mol Cell Biochem 1999;193:69-74.
64. Hufton SE, Moerkerk PT, Brandwijk R, de Bruine AP, Arends JW, Hoogenboom HR. A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization. FEBS Lett 1999;463:77-82.
65. Van Beijnum JR, Moerkerk PT, Gerbers AJ, De Bruine AP, Arends JW, Hoogenboom HR, Hufton SE. Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer. Int J Cancer 2002;101:118-127.
66. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997;25:3389-3402.